Literature DB >> 14579992

The impact of exacerbations on the asthmatic patient's preference scores.

Fredrik Andersson1, Sixten Borg, Elisabeth Ståhl.   

Abstract

The purpose of this study was to examine the effect of exacerbations on mild to moderate asthmatic patients' preference-based, health-related, quality of life scores and also to describe the effect of these exacerbations on daily life. In a survey, 100 mild to moderate asthmatic patients in the United Kingdom were asked to rate three different health marker states on a scale between 0 (death) and 100 (perfect health), defined as: your asthma of today, a mild exacerbation, and a severe exacerbation of asthma. They were also asked to describe their symptoms and what they did when experiencing an exacerbation. During exacerbations the vast majority of asthmatic patients have significant symptoms and consume a considerable amount of health care resources, which often overlap. The health marker state "your asthma of today" was given a mean score of 81.0, a mild exacerbation a score of 62.1, and a severe exacerbation a score of 25.6, indicating a large impact on patients' daily life and their health-related quality of life. In conclusion, asthmatic patients are severely affected in their health and daily living by mild and severe exacerbations. Considerable effort should be made to reduce the number and severity of exacerbations.

Entities:  

Mesh:

Year:  2003        PMID: 14579992     DOI: 10.1081/jas-120019032

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

1.  Asthma exacerbations . 1: epidemiology.

Authors:  N W Johnston; M R Sears
Journal:  Thorax       Date:  2006-08       Impact factor: 9.139

2.  Relating weather types to asthma-related hospital admissions in New York State.

Authors:  Cameron C Lee; Scott C Sheridan; Shao Lin
Journal:  Ecohealth       Date:  2012-12-06       Impact factor: 3.184

3.  Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.

Authors:  Bernd Brüggenjürgen; Dagmar Selim; Peter Kardos; Kai Richter; Claus Vogelmeier; Stephanie Roll; Wolfgang Meyer-Sabellek; Roland Buhl; Stefan N Willich
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Temporal trends in the prevalence of asthma and rhinoconjunctivitis in adolescents.

Authors:  Fernanda Agapito Pássaro Wilmer; Rosemeri Maurici; Carlos Alberto Kuntz Nazário; Kahio César Kuntz Nazário; Paula Fernanda Agapito Pássaro; Helena Elisa Piazza; Rennan Almir Bertoldi; Emílio Pizzichini; Márcia Margaret Menezes Pizzichini
Journal:  Rev Saude Publica       Date:  2015-12-31       Impact factor: 2.106

Review 5.  Can asthma control be improved by understanding the patient's perspective?

Authors:  Rob Horne; David Price; Jen Cleland; Rui Costa; Donna Covey; Kevin Gruffydd-Jones; John Haughney; Svein Hoegh Henrichsen; Alan Kaplan; Arnulf Langhammer; Anders Østrem; Mike Thomas; Thys van der Molen; J Christian Virchow; Siân Williams
Journal:  BMC Pulm Med       Date:  2007-05-22       Impact factor: 3.317

6.  What do parents want from their child's asthma treatment?

Authors:  Stefan Walzer
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.